Texas invests $50M in psychedelic drug research to treat addiction
Medical Xpress
JUNE 16, 2025
Ibogaine shows potential for promoting neuroplasticity and aiding recovery, though it carries cardiac risks that require careful management. The initiative aims to attract additional private investment and facilitate FDA approval. This summary was automatically generated using LLM.
52 
Let's personalize your content